Advances in Precision Medicine

Editor-in-Chief: Piccaluga Pier Paolo

Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine. Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.

Journal of Medicines Development Sciences

Editor-in-Chief: Boeynaems Jean Marie

The Journal of Medicines Development Sciences focuses on the discovery and development of new medicinal products. The journal publishes original research articles on medicinal chemistry, experimental pharmacology including pharmacokinetics, preclinical safety, clinical pharmacology, pharmacogenomics, clinical research, pharmacoepidemiology and pharmacoeconomics. The journal also publishes brief reports on new research findings and review articles. Articles encouraging taking the therapy from bench to bedside and creating a broad readership of young researchers, clinicians and scientists are welcome.

Cell Biology Research

Cell Biology Research (CBR) is a peer-reviewed scholarly journal dedicated to the dissemination of cutting-edge research in the field of cell biology. With a commitment to advancing our understanding of cellular processes, the journal provides a platform for scientists, researchers, and scholars to share their latest findings and insights.